Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ13611369-1,16
KB104610480,29
PKN153,46153,560,18
Msft-0,44
Nokia8,6088,624,59
IBM0,89
Mercedes-Benz Group AG46,38546,4-0,82
PFE-1,59
12.08.2026 9:24:00
Indexy online
AD Index online
select
AD Index online
 

  • 11.08.2026 19:47:49
Accenture (ACN.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
154,30 0,71 1,10 51 893
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 12.08.2026
Popis společnosti

Business Summary: Accenture plc is a global professional services company. It is engaged in providing a range of services and solutions across strategy and consulting, technology, operations, Industry X and Song. It serves clients and manages its business through three geographic markets: Americas, EMEA (Europe, Middle East and Africa) and Asia Pacific. It operates business processes on behalf of clients for specific enterprise functions, including finance and accounting, sourcing and procurement, supply chain, marketing and sales, and human resources, as well as industry-specific services, such as platform trust and safety, banking, insurance, network and health services. Its services include Cloud consulting services, customer services, cybersecurity consulting, data and artificial intelligence, digital engineering and manufacturing, managed services, metaverse solutions, Infrastructure and Capital Projects, Finance consulting, Supply chain consulting, and others.
Financial Summary: BRIEF: For the nine months ended 31 May 2026, Accenture Plc revenues increased 7% to $55.5B. Net income increased 2% to $6.38B. Revenues reflect Products segment increase of 7% to $16.89B, Financial Services segment increase of 11% to $10.49B, Communications, Media & Technology segment increase of 11% to $9.41B, EMEA segment increase of 10% to $20.38B, Americas segment increase of 3% to $27.11B, Asia-Pacific segment increase of 9% to $8.01B.



  • Poslední aktualizace: 12.08.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board and Chief Executive OfficerRobert Ford5210.12.202101.01.2014
Executive Vice President - Finance and Chief Financial OfficerPhilip Boudreau5301.07.202401.03.2020
Executive Vice President, General Counsel and SecretaryElizabeth Cushman5601.01.2025
Executive Vice President - Human ResourcesMary Moreland5901.01.2019
Executive Vice President and Group President - Medical DevicesLisa Earnhardt5601.12.202301.01.2019
Executive Vice President - Core DiagnosticsLouis Morrone4901.01.2021
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional ProductsDaniel Salvadori4701.01.2014
Executive Vice President - Diabetes CareChristopher Scoggins5601.01.2019
Senior Vice President - Rapid and Molecular DiagnosticsEric Shroff5401.01.2025
Vice President - Finance and ControllerJohn McCoy5601.01.2023